digital ulcers: Clinical Trials

4 trials for digital ulcers, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 24Completed 4

Follow digital ulcers: new trials by email Literature Review of digital ulcers trials Research Report on digital ulcers

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect and Safety of Local Injection of Botulinum Toxin Type B Against Digital Ulcer in Systemic Sclerosis
Botulinum toxin type B (2500 units / vial), Physiological saline - Systemic Sclerosis Patients With Digital Ulcers
Phase 2CompletedGunma University102016-12-122020-05-14
Riociguat in Scleroderma Associated Digital Ulcers
Riociguat, Placebo - Scleroderma, Digital Ulcers
Phase 2CompletedDinesh Khanna, MD, MS172016-09-012019-09-24
Safety and Efficacy Study of MRE0094 to Treat Chronic, Neuropathic, Diabetic Foot Ulcers
MRE0094 - Foot Ulcer, Diabetic, Diabetes Complications
Phase 2CompletedPfizer3222005-12-012012-06-01
Sildenafil for Treatment of Digital Ulcers in Patients With Systemic Sclerosis
Sildenafil therapy - Active Digital Ulcers
Phase 2CompletedCharite University, Berlin, Germany172004-02-012009-01-07

Narrower conditions

Diabetes Complications (1)  ·  Diabetic Foot (1)  ·  Foot Ulcer (1)  ·  Scleroderma, Diffuse (1)  ·  Scleroderma, Systemic (1)

Broader conditions

Skin Diseases (3)  ·  Skin and Connective Tissue Diseases (3)  ·  Connective Tissue Diseases (2)  ·  Cardiovascular Diseases (1)  ·  Diabetes Mellitus (1)  ·  Diabetic Angiopathies (1)  ·  Diabetic Neuropathies (1)  ·  Endocrine System Diseases (1)  ·  Foot Diseases (1)  ·  Leg Ulcer (1)  ·  Scleroderma, Systemic (1)  ·  Skin Ulcer (1)  ·  Vascular Diseases (1)

Interventions

2-(2-(4-chlorophenyl)ethoxy)adenosine (1)  ·  batrachotoxinin A 20-alpha-benzoate (1)  ·  rimabotulinumtoxinB (1)  ·  riociguat (1)

Sponsors

Charite University, Berlin, Germany (1)  ·  Dinesh Khanna, MD, MS (1)  ·  Gunma University (1)  ·  Pfizer (1)

Countries

United States (2)  ·  Germany (1)  ·  Japan (1)

Top investigators

Dinesh Khanna, MD (1)  ·  Dr. Gabriela Riemekasten, MD (1)  ·  Sei-ichiro Motegi (1)

Results publications

PMID 31481106